BIOR News and Press, Biora Therapeutics Inc. From 01/02/24

SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that its BioJet™ Systemic Oral Delivery Platform has met key performance milestones as part of its research collaboration...

2023-12-22 17:35:50 ET More on Biora Therapeutics Biora Therapeutics, Inc. (BIOR) Q3 2023 Earnings Call Transcript FDA clears Biora to begin Phase 1 testing of ulcerative colitis treatment Biora submits updated IND application to FDA for BT-600 Seeking Alpha&...

SAN DIEGO, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it received an Issue Notification from the U.S. Patent and Trademark Office for a patent related to the treatment of gastro...

Transaction results in nearly 60% reduction in net debt and brings $16.7 million in new capital for the company Demonstrates investor confidence in near-term catalysts for NaviCap™ and BioJet™ platforms SAN DIEGO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics,...

SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced a new research collaboration with a large pharmaceutical company for its BioJet™ Systemic Oral Delivery Platform. The new...

2023-12-04 08:20:01 ET Losers: Neximmune ( NEXI ) -36% . Garden Stage Limited Ordinary Shares ( GSIW ) -31% . ShiftPixy ( PIXY ) -17% . Harbor Custom Development ( HCDI ) -13% . Alaska Air Group ( ALK ) -12% follow global marke...

2023-12-01 09:58:28 ET DENVER, Colo., Dec. 1, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; NLS Pharmaceutics Ltd (NASDAQ: NLSP), Biora Therapeutics Inc, (NASDAQ: BIOR), NexImmune Inc (NASDAQ: NEXI), Ha...

2023-11-30 17:10:39 ET More on Biora Therapeutics Biora Therapeutics, Inc. (BIOR) Q3 2023 Earnings Call Transcript Biora submits updated IND application to FDA for BT-600 Biora IND for BT-600 delayed due to FDA request for more info Seeking Alpha’s Qua...

BT-600 will deliver a proprietary liquid formulation of tofacitinib via the NaviCap™ device for topical delivery to the colon SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, tod...

2023-11-13 21:04:02 ET Biora Therapeutics, Inc. (BIOR) Q3 2023 Earnings Conference Call November 13, 2023, 16:30 ET Company Participants Chuck Pedala - LifeSci Advisors Adi Mohanty - CEO Eric d'Esparbes - CFO Conference Call Participants Joe Pantginis...